Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010.

Gopal S, Martin KE, Richards KL, Eron JJ.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):798-805. doi: 10.1089/AID.2011.0259.

2.

Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.

Xicoy B, Ribera JM, Miralles P, Berenguer J, Rubio R, Mahillo B, Valencia ME, Abella E, López-Guillermo A, Sureda A, Morgades M, Navarro JT, Esteban H; GESIDA Group.; GELCAB Group..

Haematologica. 2007 Feb;92(2):191-8.

3.

HIV-associated non-Hodgkin's lymphoma: experience from a regional cancer center.

Sharma A, Bajpai J, Raina V, Mohanti BK.

Indian J Cancer. 2010 Jan-Mar;47(1):35-9. doi: 10.4103/0019-509X.58857.

4.

Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era.

Silverton A, Gunthel C, Adamski M, Mosunjac M, Nguyen ML.

AIDS Res Hum Retroviruses. 2014 Jul;30(7):665-9. doi: 10.1089/AID.2013.0188.

PMID:
24707838
5.

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.

Castillo JJ, Bower M, Brühlmann J, Novak U, Furrer H, Tanaka PY, Besson C, Montoto S, Cwynarski K, Abramson JS, Dalia S, Bibas M, Connors JM, Furman M, Nguyen ML, Cooley TP, Beltran BE, Collins JA, Vose JM, Xicoy B, Ribera JM; HIV-Associated Hodgkin Lymphoma in the cART Era Study Group..

Cancer. 2015 Feb 1;121(3):423-31. doi: 10.1002/cncr.29066.

6.

[Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].

Jacomet C, Lesens O, Villemagne B, Darcha C, Tournilhac O, Henquell C, Cormerais L, Gourdon F, Peigue-Lafeuille H, Travade P, Beytout J, Laurichesse H.

Med Mal Infect. 2006 Mar;36(3):157-62. French.

PMID:
16503104
7.

Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.

Simcock M, Blasko M, Karrer U, Bertisch B, Pless M, Blumer L, Vora S, Robinson JO, Bernasconi E, Terziroli B, Moirandat-Rytz S, Furrer H, Hirschel B, Vernazza P, Sendi P, Rickenbach M, Bucher HC, Battegay M, Koller MT; Swiss HIV Cohort Study..

Antivir Ther. 2007;12(6):931-9.

PMID:
17926647
8.

Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.

Gopal S, Patel MR, Yanik EL, Cole SR, Achenbach CJ, Napravnik S, Burkholder GA, Reid EG, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Eron JJ, Richards KL.

J Natl Cancer Inst. 2013 Aug 21;105(16):1221-9. doi: 10.1093/jnci/djt158.

9.

The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.

Vilchez RA, Finch CJ, Jorgensen JL, Butel JS.

Medicine (Baltimore). 2003 Mar;82(2):77-81.

10.

Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.

Hoffmann C, Hentrich M, Gillor D, Behrens G, Jensen B, Stoehr A, Esser S, van Lunzen J, Krznaric I, Müller M, Oette M, Hensel M, Thoden J, Fätkenheuer G, Wyen C.

HIV Med. 2015 Apr;16(4):261-4. doi: 10.1111/hiv.12200.

PMID:
25252101
11.

Peripheral T-cell lymphoma in HIV-infected patients: a study of 17 cases in the combination antiretroviral therapy era.

Gilardin L, Copie-Bergman C, Galicier L, Meignin V, Brière J, Timsit JF, Bouchaud O, Gaulard P, Oksenhendler E, Gérard L.

Br J Haematol. 2013 Jun;161(6):843-51. doi: 10.1111/bjh.12341.

PMID:
23593987
12.
13.

Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.

Hentrich M, Berger M, Wyen C, Siehl J, Rockstroh JK, Müller M, Fätkenheuer G, Seidel E, Nickelsen M, Wolf T, Rieke A, Schürmann D, Schmidmaier R, Planker M, Alt J, Mosthaf F, Engert A, Arasteh K, Hoffmann C.

J Clin Oncol. 2012 Nov 20;30(33):4117-23. doi: 10.1200/JCO.2012.41.8137. Erratum in: J Clin Oncol. 2012 Dec 20;30(36):4590.

PMID:
23045592
14.

Managing HIV and Hodgkin lymphoma in the twenty-first century.

Aries J, Montoto S.

Curr Hematol Malig Rep. 2014 Sep;9(3):227-32. doi: 10.1007/s11899-014-0215-4.

PMID:
24906351
16.

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH.

J Natl Cancer Inst. 1997 Feb 19;89(4):301-7.

PMID:
9048834
17.

High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.

Besson C, Lancar R, Prevot S, Brice P, Meyohas MC, Marchou B, Gabarre J, Bonnet F, Goujard C, Lambotte O, Boué F, Mounier N, Partisani M, Raffi F, Costello R, Hendel-Chavez H, Algarte-Genin M, Trabelsi S, Marchand L, Raphael M, Taoufik Y, Costagliola D.

Clin Infect Dis. 2015 Nov 1;61(9):1469-75. doi: 10.1093/cid/civ627.

PMID:
26223997
18.

[Lymphomas associated with HIV infection in patients at the Hospital San Borja Arriarán /Fundación Arriarán 2001-2008, Santiago, Chile].

Pizarro A, García H, Riquelme A, Carmona J, Cortés C.

Rev Chilena Infectol. 2013 Feb;30(1):23-30. doi: 10.4067/S0716-10182013000100004. Spanish.

19.
20.

Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma.

Baiocchi OC, Colleoni GW, Navajas EV, Duarte LC, Alves AC, Andrade AL, Kerbauy J, Oliveira JS.

Acta Oncol. 2002;41(2):192-6.

PMID:
12102166
Items per page

Supplemental Content

Support Center